{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:45Z","timestamp":1753891965699,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001268 82171298 82171301"],"award-info":[{"award-number":["82001268 82171298 82171301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>There\u2019s no evidence demonstrating the association between noncoding RNAs levels before IV recombinant tissue plasminogen activator (rtPA) administration and the outcomes of acute ischemic stroke (AIS). 145 AIS patients received rtPA treatment were recruited at the stroke center from 2018 to 2019, and 103 patients were included in this study. A panel of noncoding RNAs (miRNA-23a, miRNA-193a, miRNA-128, miRNA-99a, miRNA-let-7a, miRNA-494, miRNA-424, and lncRNA H19) were measured in the circulating neutrophils of AIS patients before rtPA treatment. Endpoints included excellent outcome (modified Rankin Scale score [mRS] 0\u20131) or poor outcome (mRS &amp;gt; 1) at 3\u00a0months and symptomatic intracerebral hemorrhage (sICH) after rtPA treatment. Among the eight noncoding RNAs detected in circulating neutrophils of the 103 participants, miRNA-23a levels were associated with the stroke severity on admission and symptom progression at 24\u00a0h after rtPA treatment. A noncoding RNA score composed of miRNA-23a, miRNA-99a, and lncRNA H19 was screened to predict the functional outcome at 3 months and the incidence of sICH after rtPA treatment. In the logistic regression analysis, the noncoding RNA score \u2265 \u22120.336 (OR = 2.862 [1.029\u20137.958], <jats:italic>p<\/jats:italic> = 0.044) was an independent predictor of the poor outcome at 3\u00a0months after adjustment of clinical variables, the addition of the noncoding RNA score to the clinical model improved the discrimination (IDI% = 4.68 [0.65\u20138.71], <jats:italic>p<\/jats:italic> = 0.020), as well as the net reclassification (NRI% = 33.04 [0.54\u201371.49], <jats:italic>p<\/jats:italic> = 0.016). The noncoding RNA score \u2265 \u22120.336 (OR = 5.250 [1.096\u201325.135], <jats:italic>p<\/jats:italic> = 0.038) was also independently predicted the sICH, the addition of the noncoding RNA score to the clinical variables improved discrimination and reclassification as well. The noncoding RNA score was also associated with the infarct volume and symptom improvement at 7\u00a0days after rtPA treatment. In conclusion, a higher neutrophilic noncoding RNA score provides predictive value to identify AIS patients with worse outcomes after rtPA treatment. miRNA-23a, miRNA-99a, and lncRNA H19 are worth further investigation for their effects in thrombolysis after AIS.<\/jats:p>","DOI":"10.3389\/fphar.2022.1003806","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:31:28Z","timestamp":1665059488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziping","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangmin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E3107","DOI":"10.3390\/ijms21093107","article-title":"Changes in whole-blood microRNA profiles during the onset and treatment process of cerebral infarction: A human study","volume":"21","author":"Abe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"B3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ana.24309","article-title":"Neural function, injury, and stroke subtype predict treatment gains after stroke","volume":"77","author":"Burke Quinlan","year":"2015","journal-title":"Ann. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1161\/STROKEAHA.116.013869","article-title":"Altered expression of Long noncoding RNAs in blood after ischemic stroke and proximity to putative stroke risk loci","volume":"47","author":"Dykstra-Aiello","year":"2016","journal-title":"Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"108260","DOI":"10.1016\/j.celrep.2020.108260","article-title":"Neutrophils obstructing brain capillaries are a major cause of No-reflow in ischemic stroke","volume":"33","author":"El Amki","year":"2020","journal-title":"Cell. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-021-02090-6","article-title":"The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke","volume":"18","author":"Gong","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2019.08.002","article-title":"Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis","volume":"289","author":"He","year":"2019","journal-title":"Atherosclerosis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: Translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10571-020-01028-5","article-title":"MicroRNA: An emerging predictive, diagnostic, prognostic and therapeutic strategy in ischaemic stroke","volume":"42","author":"Kadir","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/CIRCRESAHA.117.311758","article-title":"A biomarker ocular: Circulating MicroRNAs toward diagnostics for acute ischemic stroke","volume":"121","author":"Karakas","year":"2017","journal-title":"Circ. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/nyas.13612","article-title":"Noncoding RNAs in ischemic stroke: Time to translate","volume":"1421","author":"Kaur","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1096\/fj.201903127R","article-title":"Intravenous antagomiR-494 lessens brain-infiltrating neutrophils by increasing HDAC2-mediated repression of multiple MMPs in experimental stroke","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.14336\/AD.2017.0602","article-title":"Diagnostic and immunosuppressive potential of elevated mir-424 levels in circulating immune cells of ischemic stroke patients","volume":"9","author":"Li","year":"2018","journal-title":"Aging Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/cns.13829","article-title":"Long non-coding RNA H19 promotes leukocyte inflammation in ischemic stroke by targeting the miR-29b\/C1QTNF6 axis","volume":"28","author":"Li","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.pneurobio.2017.08.002","article-title":"Impact of microRNAs on ischemic stroke: From pre- to post-disease","author":"Li","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.7150\/thno.68895","article-title":"M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1177\/0963689719846848","article-title":"Upregulation of MicroRNA-128 in the peripheral blood of acute ischemic stroke patients is correlated with stroke severity partially through inhibition of neuronal cell cycle reentry","volume":"28","author":"Liu","year":"2019","journal-title":"Cell. Transpl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/STROKEAHA.114.007482","article-title":"MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress","volume":"46","author":"Liu","year":"2015","journal-title":"Stroke"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.str.25.11.2220","article-title":"Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group","volume":"25","author":"Lyden","year":"1994","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0000000000002029","article-title":"Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes","volume":"85","author":"Maestrini","year":"2015","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1161\/STROKEAHA.117.016735","article-title":"Classification of bleeding events: Comparison of ECASS III (European cooperative acute stroke study) and the new heidelberg bleeding classification","volume":"48","author":"Neuberger","year":"2017","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1161\/STROKEAHA.119.026848","article-title":"Pharmacological modulation of neutrophil extracellular traps reverses thrombotic stroke tPA (Tissue-Type plasminogen activator) resistance","volume":"50","author":"Pe\u00f1a-Mart\u00ednez","year":"2019","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","article-title":"Statistical methods for assessment of added usefulness of new biomarkers","volume":"48","author":"Pencina","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American heart association\/American stroke association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"B25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","article-title":"tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke","volume":"128","author":"Shi","year":"2021","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/STROKEAHA.118.023648","article-title":"Serum MicroRNA-based risk prediction for stroke","volume":"50","author":"Sonoda","year":"2019","journal-title":"Stroke"},{"key":"B27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2015.05.036","article-title":"Neuroprotective effect of microRNA-99a against focal cerebral ischemia-reperfusion injury in mice","volume":"355","author":"Tao","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.str.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12174","DOI":"10.7150\/thno.48135","article-title":"Remote postconditioning ameliorates stroke damage by preventing let-7a and miR-143 up-regulation","volume":"10","author":"Vinciguerra","year":"2020","journal-title":"Theranostics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1161\/STROKEAHA.117.017387","article-title":"Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-dependent M1 microglial polarization","volume":"48","author":"Wang","year":"2017","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1212\/WNL.0000000000008862","article-title":"Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury","volume":"94","author":"Wu","year":"2020","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32:aid-cncr2820030106>3.0.co;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(18)31874-9","article-title":"Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke","volume":"392","author":"Zerna","year":"2018","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/bc.bc_1_17","article-title":"MicroRNA-99a-5p in circulating immune cells as a potential biomarker for the early diagnosis of ischemic stroke","volume":"3","author":"Zhao","year":"2017","journal-title":"Brain Circ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2014.09.055","article-title":"MicroRNA-23a-3p attenuates oxidative stress injury in a mouse model of focal cerebral ischemia-reperfusion","volume":"1592","author":"Zhao","year":"2014","journal-title":"Brain Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1003806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T12:31:31Z","timestamp":1665059491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1003806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":37,"alternative-id":["10.3389\/fphar.2022.1003806"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1003806","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"1003806"}}